Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran

Mohammadreza Mahzounieh 1 , * , Mohammadreza Ghorani 2 , Ali Karimi 3 , Batoul Pourgheysari 4 and Razieh Nikoozad 5
Authors Information
1 Pathobiology Department, Research Institute of Zoonotic Diseases, Shahrekord University, Shahrekord, IR Iran
2 Department of Microbiology, Tehran University, Tehran, IR Iran
3 Microbiology and Immunology Department, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Pathology and Hematology Department, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
5 Department of Microbiology, Islamic Azad University, Falavarjan Branch, Falavarjan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: June 01, 2015, 8 (6); e17201
  • Published Online: June 27, 2015
  • Article Type: Research Article
  • Received: December 27, 2013
  • Revised: May 18, 2014
  • Accepted: June 2, 2014
  • DOI: 10.5812/jjm.8(5)2015.17201

To Cite: Mahzounieh M, Ghorani M, Karimi A, Pourgheysari B, Nikoozad R. Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran, Jundishapur J Microbiol. 2015 ; 8(6):e17201. doi: 10.5812/jjm.8(5)2015.17201.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12): 7415-9[PubMed]
  • 2. Kalyanaraman VS, Sarngadharan MG, Poiesz B, Ruscetti FW, Gallo RC. Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol. 1981; 38(3): 906-15[PubMed]
  • 3. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007; 7(4): 270-80[DOI][PubMed]
  • 4. Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Pathol. 2001; 82(3): 135-47[PubMed]
  • 5. Monplaisir N, Neisson-Vernant C, Bouillot M, Duc-Dodon M, Ugarte E, Valette I, et al. HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction. AIDS Res Hum Retroviruses. 1993; 9(9): 869-74[PubMed]
  • 6. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989; 111(7): 555-60[PubMed]
  • 7. Rafatpanah H, Farid R, Golanbar G, Azad FJ. HTLV-I Infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals. Iran J Allergy Asthma Immunol. 2006; 5(4): 153-66
  • 8. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992; 51(6): 886-91[PubMed]
  • 9. Ghaffari J, Kowsarian M, Mahdavi M, Vahid Shahi K, Rafatpanah H, Tafreshian A. Prevalence of HTLV-I Infection in Patients with Thalassemia Major in Mazandaran, North of Iran. Jundishapur J Microbiol. 2012; 6(1): 57-60[DOI]
  • 10. Inoue H, Matsushita K, Arima N, Hamada H, Uozumi K, Ozaki A, et al. High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia. Leuk Lymphoma. 2008; 49(2): 315-21[DOI][PubMed]
  • 11. Starkebaum G, Loughran TJ, Kalyanaraman VS, Kadin ME, Kidd PG, Singer JW, et al. Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet. 1987; 1(8533): 596-9[PubMed]
  • 12. Adedayo OA, Shehu SM. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: a seroprevalence study. Am J Hematol. 2004; 77(4): 336-9[DOI][PubMed]
  • 13. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39): 6058-68[DOI][PubMed]
  • 14. Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009; 41(5): 498-9[PubMed]
  • 15. Azarpazjhoo M, Hasanpoor K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati Moghaddam M. HTLV-I prevalence in Northeastern Iran, Sabzevar; An epidemiologic based study and phylogenetic analysis. AIDS Res Hum Retrovir. 2012; 28(9): 1095-101
  • 16. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
  • 17. Karimi A, Nafici M, Imani R. Comparison of human T-cell leukemia virus type-1 (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari Province, Iran. Kuwait Med J. 2007; 39(3): 259-61
  • 18. Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008; 19(5): 838-41[PubMed]
  • 19. Dehée A, Césaire R, Désiré N, Lézin A, Bourdonné O, Béra O, et al. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods. 2002; 102(1): 37-51
  • 20. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997; 15: 15-37[DOI][PubMed]
  • 21. Dougan S, Payne LJ, Tosswill JH, Davison K, Evans BG. HTLV infection in England and Wales in 2002--results from an enhanced national surveillance system. Commun Dis Public Health. 2004; 7(3): 207-11[PubMed]
  • 22. Payne LJ, Tosswill JH, Taylor GP, Zuckerman M, Simms I. In the shadow of HIV-HTLV infection in England and Wales, 1987-2001. Commun Dis Public Health. 2004; 7(3): 200-6[PubMed]
  • 23. Chiewsilp P, Iamsilp W, Hathirat P. HTLV-I antibody screening in donated blood and thalassemic patients. J Med Assoc Thai. 1993; 76 Suppl 2: 103-5[PubMed]
  • 24. Covas DT, Boturao Neto E, Zago MA. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients. Rev Inst Med Trop Sao Paulo. 1993; 35(3): 271-3[PubMed]
  • 25. Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, et al. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 15(3): 238-42[PubMed]
  • 26. Miyagi J, Toda T, Uezato H, Ohshima K, Miyakuni T, Takasu N, et al. Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan. Int J Hematol. 2002; 75(1): 78-84[PubMed]
  • 27. Barrientos A, Lopez M, Sotomayor C, Pilleux L, Calderon S, Navarrete M, et al. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile. J Med Virol. 2011; 83(4): 745-8[DOI][PubMed]
  • 28. Monavari SH, Keyvani H, Salehi Vaziri M, Bokharaei Salim F. Detection of human T-cell lymphotropic virus Type-1 among patients with malignant hematological diseases in Capital of Iran, Tehran. J General Mol Virol. 2011; 3(5): 67-70
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments